Education
About Us
Working with TipRanks
Follow Us
Acura Pharmaceuticals (ACUR)
OTHER OTC:ACUR
ACUR Stock Chart & Stats
$0.01
>-$0.01(-94.29%)
At close: 4:00 PM EST
$0.01
>-$0.01(-94.29%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.18
Previous CloseN/A
Volume52.13K
Average Volume (3M)260.00
Market Cap
$33.00K
Enterprise ValueN/A
Total Cash (Recent Filing)$65.00K
Total Debt (Recent Filing)$200.00K
Price to Earnings (P/E)―
Beta-17.66
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding66,001,785
10 Day Avg. Volume100
30 Day Avg. Volume260
Financial Highlights & Ratios
PEG Ratio0.42
Price to Book (P/B)159.55
Price to Sales (P/S)18.17
P/FCF Ratio-38.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Acura Pharmaceuticals News
ACUR FAQ
What was Acura Pharmaceuticals’s price range in the past 12 months?
Acura Pharmaceuticals lowest stock price was <$0.01 and its highest was $0.17 in the past 12 months.
What is Acura Pharmaceuticals’s market cap?
Acura Pharmaceuticals’s market cap is $33.00K.
When is Acura Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Acura Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is Acura Pharmaceuticals overvalued?
According to Wall Street analysts Acura Pharmaceuticals’s price is currently Overvalued.
Does Acura Pharmaceuticals pay dividends?
Acura Pharmaceuticals does not currently pay dividends.
What is Acura Pharmaceuticals’s EPS estimate?
Acura Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acura Pharmaceuticals have?
Acura Pharmaceuticals has 66,001,785 shares outstanding.
What happened to Acura Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Acura Pharmaceuticals?
Currently, no hedge funds are holding shares in ACUR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Acura Pharmaceuticals
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was incorporated in 1935 and is based in Palatine, Illinois.
Technical Analysis
China Pharma Holdings
―
―
RedHill Biopharma
―
Cumberland Pharmaceuticals
―
PainReform
―
Ownership Overview
5.49% Insiders
<0.01% Other Institutional Investors
94.51% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---